3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method.

In the present study, a series of novel azaoxoisoaporphine derivatives were reported and their inhibitory activities toward acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and Aβ aggregation were evaluated. The new compounds remained high inhibitory potency on Aβ aggregation, with inhibitory activity from 29.42% to 89.63% at a concentration of 10μM, but had no action on AChE or BuChE, which was very different from our previously reported oxoaporphine and oxoisoaporphine derivatives. By 3D-QSAR studies, we constructed a reliable CoMFA model (q(2)=0.856 and r(2)=0.986) based on the inhibitory activities toward AChE and discovered key information on structure and anti-AChE activities among the azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives. The model was further confirmed by the test-set validation (q(2)=0.873, r(2)=0.937, and slope k=0.902) and Y-randomization examination. The statistically significant and physically meaningful 3D-QSAR/CoMFA model provided better insight into understanding the inhibitory behaviors of those chemicals, which may provide useful information for the rational molecular design of azaoxoisoaporphine derivatives anti-AChE and anti-AD agents.

[1]  A. Chan,et al.  Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[2]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[3]  Ding Li,et al.  Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation. , 2011, European journal of medicinal chemistry.

[4]  S. Wold,et al.  The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .

[5]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[6]  S. Hecht,et al.  A DNA-damaging oxoaporphine alkaloid from Piper caninum. , 2004, Journal of natural products.

[7]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[8]  J. Lehmann,et al.  Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. , 2010, Journal of medicinal chemistry.

[9]  G. Qin,et al.  Cytotoxic oxoisoaporphine alkaloids from Menispermum dauricum. , 2001, Journal of natural products.

[10]  Wei Qiao,et al.  Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase. , 2009, European journal of medicinal chemistry.

[11]  L. Mucke Neuroscience: Alzheimer's disease , 2009, Nature.

[12]  George Kollias,et al.  Molecular Modeling on Pyrimidine-Urea Inhibitors of TNF-α Production: An Integrated Approach Using a Combination of Molecular Docking, Classification Techniques, and 3D-QSAR CoMSIA , 2012, J. Chem. Inf. Model..

[13]  P. Wakeley,et al.  Synthesis , 2013, The Role of Animals in Emerging Viral Diseases.

[14]  A. Tropsha,et al.  Beware of q 2 , 2002 .

[15]  Zhishu Huang,et al.  A facile and efficient method for hydroxylation of azabenzanthrone compounds , 2011 .

[16]  Matthew Clark,et al.  The Probability of Chance Correlation Using Partial Least Squares (PLS) , 1993 .

[17]  Bruce L. Bush,et al.  Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA , 1993, J. Comput. Aided Mol. Des..

[18]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[19]  Xiaopeng Hu,et al.  Quantitative structure-retention relationship of curcumin and its analogues. , 2012, Journal of separation science.

[20]  S. Wold Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .

[21]  George Kollias,et al.  Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors , 2009, Molecular Diversity.

[22]  C. Theoduloz,et al.  Synthesis of lakshminine and antiproliferative testing of related oxoisoaporphines. , 2010, Journal of natural products.

[23]  R. Cramer,et al.  Recent advances in comparative molecular field analysis (CoMFA). , 1989, Progress in clinical and biological research.